Heart Failure in the Child and Young Adult

<p>Section I: Basic Science of Heart Failure <br>1. Molecular and Cellular Mechanisms in Heart Failure<br>2. Cardiovascular Receptors and Signaling in Heart Failure<br>3. Inflammatory Mediators in Heart Failure<br>4. Mechanisms of Hypertrophy in Heart Failure<br>5. Hemodynamic Adaptive Mechanisms in Heart Failure<br>6. Neurohormonal Axis and Natriuretic Peptides in Heart Failure <br>7. The Pressure-Volume Relationship in Heart Failure <br>8. Systolic and Diastolic Dysfunction Mechanisms and Assessment of Systolic vs Diastolic Heart Failure <br>9. The Alveolar-Capillary Interface and Pulmonary Edema<br>10. Echocardiographic Quantitation of Ventricular Function<br>11. Magnetic Resonance Imaging Assessment of Heart Failure<br>12. Assessment of Heart Failure by Invasive Methods</p> <p>Section II: Clinical Diagnosis and Management of Pediatric Heart Failure<br>13. Epidemiology and Economic Aspects of Pediatric Heart Failure<br>14. Clinical Recognition of Congestive Heart Failure in Children<br>15. Classification of Heart Failure<br>16. Right Ventricular Dysfunction<br>17. Pediatric Myocarditis<br>18. Dilated Cardiomyopathy<br>19. Clinical Features of Restrictive Cardiomyopathy and Constrictive Pericarditis<br>20. Hypertrophic Cardiomyopathy<br>21. Left Ventricular Noncompaction<br>22. Arrhythmogenic Cardiomyopathies <br>23. Valvular Insufficiency and Heart Failure<br>24. Valvular Stenosis and Heart Failure<br>25. Coronary Artery Disease in Children and Young Adults<br>26. Heart Failure in Congenital Heart Disease Including Single Ventricle Circulation<br>27. Heart Failure in Adults With Congenital Heart Disease<br>28. Dysrhythmias and Ventricular Dysfunction and Heart Failure <br>29. Heart Failure in the Fetus<br>30. Heart Failure in the Neonate<br>31. Heart Failure in Pediatric Pulmonary Diseases<br>32. Heart Failure and the Pediatric Cardiorenal Syndrome<br>33. Heart Failure in Pediatric Oncologic Disease<br>34. The Failing Cardiovascular System in Sepsis<br>35. Outpatient Management of Pediatric Heart Failure<br>36. Quality of Life and Psychosocial Care in Pediatric Heart Failure<br>37. Quality Metrics and Quality Improvement in Pediatric Heart Failure<br>38. Nursing Aspects of Heart Failure</p> <p>Section III: Medical Treatment for Pediatric Heart Failure<br>39. Diuretics and Invasive Fluid Management Strategies<br>40. Inotropic Agents in Heart Failure<br>41. Phosphodiesterase Inhibitors<br>42. Use of Vasodilators in Heart Failure<br>43. Beta-adrenergic Receptor Blockade<br>44. Low Cardiac Output Syndrome in the Intensive Care Setting <br>45. New Therapeutic Strategies in Heart Failure <br>46. Electrophysiologic Devices in Heart Failure<br>47. Catheter Device Therapy for Heart Failure</p> <p>Section IV: Cardiac Surgery and Pediatric Heart Failure<br>48. Post-Transplant Heart Failure<br>49. Surgical Strategies for the Failing Systemic Ventricle<br>50. Valve Intervention for Valve Failure <br>51. General Principles of Mechanical Cardiopulmonary Support <br>52. Short-Term Mechanical Cardiopulmonary Support Devices <br>53. Decision Making in Ventricular Assist Device Support in Pediatric Patients<br>54. Long Term Ventricular Assist Devices in Children<br>55. The Adult Experience with Long-Term Assist Devices<br>56. Future of Mechanical Support Devices in Children and Young Adults </p> <p>Section V: Special Topics<br>57. Genetics and Genomics<br>58. Genetic Testing <br>59. Data Management and Analytics <br>60. Self-Management and Outpatient Monitoring <br>61. Regenerative Medicine and Nanomedicine <br>62. Nanomedicine<br>63. Nutritional Assessment and Management in Pediatric Heart Failure</p>